Both IFN-γ and IL-17 are thought to enhance immune activation and have been strongly associated in human disease, as the frequencies of Th1 and Th17 cells are increased in MS lesions and the cerebrospinal fluid (CSF) (130, 143). The gene discussed is IL17A; the disease is myeloid sarcoma.